1. Home
  2. LPSN vs POM Comparison

LPSN vs POM Comparison

Compare LPSN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

HOLD

Current Price

$3.28

Market Cap

47.0M

Sector

Technology

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.30

Market Cap

38.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
LPSN
POM
Founded
1995
2015
Country
United States
China
Employees
N/A
N/A
Industry
EDP Services
Other Specialty Stores
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
38.8M
IPO Year
2000
2025

Fundamental Metrics

Financial Performance
Metric
LPSN
POM
Price
$3.28
$0.30
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
211.4K
941.2K
Earning Date
03-04-2026
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$257,660,000.00
$51,210,721.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.13
52 Week Low
$2.94
$0.26
52 Week High
$23.55
$6.43

Technical Indicators

Market Signals
Indicator
LPSN
POM
Relative Strength Index (RSI) 35.40 N/A
Support Level $2.94 N/A
Resistance Level $4.12 N/A
Average True Range (ATR) 0.22 0.00
MACD -0.05 0.00
Stochastic Oscillator 29.11 0.00

Price Performance

Historical Comparison
LPSN
POM

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: